Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Hair cortisol levels may not reliably indicate psychological distress.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Aromatase inhibitors cause male pattern hair loss in women.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Beards and long hair may affect how attractive someone is to the opposite sex.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Genes and hormones cause hair loss, with four genes contributing equally.

Hypothyroidism and hyperprolactinemia may cause hair loss in women.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Steroid hormones are vital for body functions and disease management.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.